Gharpure, R., Vegvari, C., Abdissa, A., Alimi, Y., Anyamba, A., Auerbach, J., . . . Hart, P. (2025). Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4–5 June 2024. Gharpure, R., Vegvari, C., Abdissa, A., Alimi, Y., Anyamba, A., Auerbach, J., Bett, B., Bird, B.H., Bob, N.S., Breugelmans, J.G., Clark, J., Cleaveland, S., Cramer, J., Dawa, J., Fay, P.C., Formenty, P., Gerdts, V., Gerken, K.N., Gitonga, J., Groschup, M., Heighway, J., Johnson, S.A.M., Juma, J., Kading, R.C., Kamau, M., Kerama, S., Lubisi, B.A., Lutwama, J., Luyimbazi, D., Marami, D., Moore, S.M., Muturi, M., Mwangoka, G., Ndiu, A., Njenga, M.K., Njouom, R., Nyakarahuka, L., Nzietchueng, S., Oloo, P., Otiende, M., Oyola, S., Paganini, L.S., Pandit, P.S., Punt, C., Samy, A.M., Situma, S., Sneddon, H., Bosch, Q.A. ten, Tezcan-Ulger, S., Thompson, P.N., Tildesley, M., Tinto, B., Vesga, J.F., Wichgers Schreur, P.P. and Hart, P. 2025. Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4–5 June 2024. Vaccine 54: 126860.
Παραπομπή σε μορφή Chicago (17η εκδ.)Gharpure, R., et al. "Meeting Report: CEPI Workshop on Rift Valley Fever Epidemiology and Modeling to Inform Human Vaccine Development, Nairobi, 4–5 June 2024." Gharpure, R., Vegvari, C., Abdissa, A., Alimi, Y., Anyamba, A., Auerbach, J., Bett, B., Bird, B.H., Bob, N.S., Breugelmans, J.G., Clark, J., Cleaveland, S., Cramer, J., Dawa, J., Fay, P.C., Formenty, P., Gerdts, V., Gerken, K.N., Gitonga, J., Groschup, M., Heighway, J., Johnson, S.A.M., Juma, J., Kading, R.C., Kamau, M., Kerama, S., Lubisi, B.A., Lutwama, J., Luyimbazi, D., Marami, D., Moore, S.M., Muturi, M., Mwangoka, G., Ndiu, A., Njenga, M.K., Njouom, R., Nyakarahuka, L., Nzietchueng, S., Oloo, P., Otiende, M., Oyola, S., Paganini, L.S., Pandit, P.S., Punt, C., Samy, A.M., Situma, S., Sneddon, H., Bosch, Q.A. Ten, Tezcan-Ulger, S., Thompson, P.N., Tildesley, M., Tinto, B., Vesga, J.F., Wichgers Schreur, P.P. and Hart, P. 2025. Meeting Report: CEPI Workshop on Rift Valley Fever Epidemiology and Modeling to Inform Human Vaccine Development, Nairobi, 4–5 June 2024. Vaccine 54: 126860 2025.
Παραπομπή σε μορφή MLA (9th εκδ.)Gharpure, R., et al. "Meeting Report: CEPI Workshop on Rift Valley Fever Epidemiology and Modeling to Inform Human Vaccine Development, Nairobi, 4–5 June 2024." Gharpure, R., Vegvari, C., Abdissa, A., Alimi, Y., Anyamba, A., Auerbach, J., Bett, B., Bird, B.H., Bob, N.S., Breugelmans, J.G., Clark, J., Cleaveland, S., Cramer, J., Dawa, J., Fay, P.C., Formenty, P., Gerdts, V., Gerken, K.N., Gitonga, J., Groschup, M., Heighway, J., Johnson, S.A.M., Juma, J., Kading, R.C., Kamau, M., Kerama, S., Lubisi, B.A., Lutwama, J., Luyimbazi, D., Marami, D., Moore, S.M., Muturi, M., Mwangoka, G., Ndiu, A., Njenga, M.K., Njouom, R., Nyakarahuka, L., Nzietchueng, S., Oloo, P., Otiende, M., Oyola, S., Paganini, L.S., Pandit, P.S., Punt, C., Samy, A.M., Situma, S., Sneddon, H., Bosch, Q.A. Ten, Tezcan-Ulger, S., Thompson, P.N., Tildesley, M., Tinto, B., Vesga, J.F., Wichgers Schreur, P.P. and Hart, P. 2025. Meeting Report: CEPI Workshop on Rift Valley Fever Epidemiology and Modeling to Inform Human Vaccine Development, Nairobi, 4–5 June 2024. Vaccine 54: 126860, 2025.